Document is current
Any future updates will be listed below
-
Authors
Watts, Justin M.
Shaw, Simon J.
Jonas, Brian A.
- License Information
-
More Information
Article History
Accepted: 15 September 2024
First Online: 16 October 2024
Compliance with Ethical Standards
:
: J.M.W. received consulting fees and/or participated in advisory boards for Rigel, Servier, BMS, Daiichi-Sankyo, Aptose, and Ativarre; S.J.S. was an employee and shareholder of Rigel Pharmaceuticals, Inc. at the time of manuscript drafting; B.A.J. served in a consultancy/advisory role for AbbVie, Bristol Myers Squibb, Daiichi Sankyo, Genentech, Gilead, GlycoMimetics, Kymera, Kura, Rigel, Schrodinger, Servier, Syndax and Treadwell, on a protocol steering committee for GlycoMimetics, on a data monitoring committee for Gilead, received travel reimbursement from AbbVie and Rigel, research funding to institution from AbbVie, Amgen, Aptose, AROG, Biomea, Bristol Myers Squibb, Celgene, Daiichi Sankyo, F. Hoffmann‑La Roche, Forma, Forty‑Seven, Genentech/Roche, Gilead, GlycoMimetics, Hanmi, Immune‑Onc, Incyte, Jazz, Kymera, Loxo, Pfizer, Pharmacyclics, Sigma Tau, and Treadwell.
: This article does not contain anystudies with human or animal subjects performed by any of the authors.
